All Work

Chris Lange

Evoqua Announces Potential Pricing for IPO

Evoqua Water Technologies expects to price more than 27 million shares so that its initial public offering is valued up to nearly $607 million.

Chris Lange · 9 years ago

Why Spectrum Pharmaceuticals Shares Are Surging

Spectrum Pharmaceuticals saw its shares make a solid gain early on Wednesday after the firm announced interim data from its mid-stage trial for the treatment of non-small cell lung cancer.

Chris Lange · 9 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a positive day for the U.S. broad markets with all exchanges hitting new all-time highs and the Dow breaking above 23,000. Crude oil started out the week with a solid gain, but…

Chris Lange · 9 years ago

Why Morgan Stanley Is Tuesday’s Top Bank

Morgan Stanley released better-than-expected quarterly results before the markets opened on Tuesday, and it proved to be the top investment house on Tuesday.

Chris Lange · 9 years ago

Monday’s Biggest Winners and Losers in the S&P 500

Monday was a positive day for the U.S. broad markets with all exchanges hitting new all-time highs. Crude oil started out the week with a solid gain, pushing farther past $50. The S&P 500…

Chris Lange · 9 years ago

JPMorgan and Goldman Sachs Push DJIA Even Higher Monday

October 16, 2017: Markets opened higher Friday following a strong report from the Empire State Manufacturing with the General Business Conditions Index blowing out the consensus. Gasoline prices at the pump continued to drop…

Chris Lange · 9 years ago

Credit Unions File Class Action Suits Against Equifax

About every six months a massive hack puts millions of consumers and average citizens at risk as cyber thieves look to get their hands on private data. Equifax was the most recent target, and…

Chris Lange · 9 years ago

Is It Time to Abandon Ship on Sears?

Sears saw its shares take a step back early on Monday after it was announced that there would be a big change in its board of directors.

Chris Lange · 9 years ago

Exelixis Cancer Treatment Hits Key Milestone

Exelixis kicked off the week with a couple updates that are already having a big impact on the stock. These updates came in the form of a key FDA approval.

Chris Lange · 9 years ago